Literature DB >> 35787689

Improving efficacy of ASO therapy in SMA.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35787689     DOI： 10.1038/d41573-022-00115-0

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   112.288


× No keyword cloud information.
  1 in total

1.  Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy.

Authors:  Luciano E Marasco; Gwendal Dujardin; Rui Sousa-Luís; Ying Hsiu Liu; Jose N Stigliano; Tomoki Nomakuchi; Nick J Proudfoot; Adrian R Krainer; Alberto R Kornblihtt
Journal:  Cell       Date:  2022-06-09       Impact factor: 66.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.